Northern Trust’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-436,169
Closed -$12.8M 4296
2017
Q3
$12.8M Sell
436,169
-4,231
-1% -$119K ﹤0.01% 2038
2017
Q2
$11.6M Buy
440,400
+50,039
+13% +$1.23M ﹤0.01% 2068
2017
Q1
$9.13M Buy
390,361
+6,794
+2% +$168K ﹤0.01% 2179
2016
Q4
$9.65M Buy
383,567
+10,792
+3% +$272K ﹤0.01% 2138
2016
Q3
$10.5M Buy
372,775
+11,479
+3% +$294K ﹤0.01% 2038
2016
Q2
$8.91M Buy
361,296
+6,291
+2% +$156K ﹤0.01% 2094
2016
Q1
$7.85M Buy
355,005
+3,733
+1% +$99.3K ﹤0.01% 2127
2015
Q4
$12.3M Sell
351,272
-11,005
-3% -$345K ﹤0.01% 1856
2015
Q3
$10.3M Buy
362,277
+19,182
+6% +$644K ﹤0.01% 1974
2015
Q2
$11.4M Sell
343,095
-7,510
-2% -$231K ﹤0.01% 1979
2015
Q1
$9.88M Buy
350,605
+1,534
+0.4% +$38.1K ﹤0.01% 2090
2014
Q4
$7.23M Sell
349,071
-14,586
-4% -$346K ﹤0.01% 2257
2014
Q3
$8.88M Sell
363,657
-12,154
-3% -$322K ﹤0.01% 2117
2014
Q2
$10.7M Sell
375,811
-47,889
-11% -$1.33M ﹤0.01% 2004
2014
Q1
$11.9M Sell
423,700
-25,902
-6% -$636K ﹤0.01% 1974
2013
Q4
$9.67M Sell
449,602
-44,643
-9% -$811K ﹤0.01% 2112
2013
Q3
$6.56M Buy
494,245
+19,032
+4% +$256K ﹤0.01% 2323
2013
Q2
$6.59M Buy
+475,213
New +$6.73M ﹤0.01% 2231

Northern Trust's PMC Position: Q4 2017 in Review

Northern Trust sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 436,169 shares — an estimated $12.8M sold.

Northern Trust first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $12.8M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Northern Trust reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Northern Trust sold 436,169 PharMerica Corporation shares in Q4 2017, an estimated $12.8M.
  • Northern Trust first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
  • Northern Trust's PharMerica Corporation position peaked at $12.8M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Northern Trust's 13F filing for Q4 2017, filed 14 Feb 2018.